Windtree Therapeutics Management
Management criteria checks 3/4
Windtree Therapeutics' CEO is Craig Fraser, appointed in Feb 2016, has a tenure of 8.75 years. total yearly compensation is $693.63K, comprised of 80.3% salary and 19.7% bonuses, including company stock and options. directly owns 0.099% of the company’s shares, worth $4.40K. The average tenure of the management team and the board of directors is 4.5 years and 0.8 years respectively.
Key information
Craig Fraser
Chief executive officer
US$693.6k
Total compensation
CEO salary percentage | 80.3% |
CEO tenure | 8.8yrs |
CEO ownership | 0.1% |
Management average tenure | 4.5yrs |
Board average tenure | less than a year |
Recent management updates
Recent updates
Windtree Therapeutics CEO Craig Fraser - Breaking Down Acute Heart Failure (Video)
Dec 06Windtree Therapeutics: Addressing Underserved And Expensive Acute Conditions
Jul 06Shareholders Will Likely Find Windtree Therapeutics, Inc.'s (NASDAQ:WINT) CEO Compensation Acceptable
Jun 09Should You Take Comfort From Insider Transactions At Windtree Therapeutics, Inc. (NASDAQ:WINT)?
Feb 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$11m |
Mar 31 2024 | n/a | n/a | -US$6m |
Dec 31 2023 | US$694k | US$557k | -US$20m |
Sep 30 2023 | n/a | n/a | -US$25m |
Jun 30 2023 | n/a | n/a | -US$24m |
Mar 31 2023 | n/a | n/a | -US$35m |
Dec 31 2022 | US$941k | US$545k | -US$39m |
Sep 30 2022 | n/a | n/a | -US$43m |
Jun 30 2022 | n/a | n/a | -US$47m |
Mar 31 2022 | n/a | n/a | -US$67m |
Dec 31 2021 | US$2m | US$480k | -US$68m |
Sep 30 2021 | n/a | n/a | -US$62m |
Jun 30 2021 | n/a | n/a | -US$63m |
Mar 31 2021 | n/a | n/a | -US$35m |
Dec 31 2020 | US$770k | US$460k | -US$33m |
Sep 30 2020 | n/a | n/a | -US$32m |
Jun 30 2020 | n/a | n/a | -US$31m |
Mar 31 2020 | n/a | n/a | -US$27m |
Dec 31 2019 | US$1m | US$452k | -US$27m |
Sep 30 2019 | n/a | n/a | -US$43m |
Jun 30 2019 | n/a | n/a | -US$40m |
Mar 31 2019 | n/a | n/a | -US$37m |
Dec 31 2018 | US$5m | US$437k | -US$35m |
Sep 30 2018 | n/a | n/a | -US$9m |
Jun 30 2018 | n/a | n/a | -US$13m |
Mar 31 2018 | n/a | n/a | -US$17m |
Dec 31 2017 | US$641k | US$425k | -US$25m |
Compensation vs Market: Craig's total compensation ($USD693.63K) is about average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Craig's compensation has been consistent with company performance over the past year.
CEO
Craig Fraser (59 yo)
8.8yrs
Tenure
US$693,625
Compensation
Mr. Craig E. Fraser is Chairman of the Board at Windtree Therapeutics, Inc. since June 22, 2023. He has been Chief Executive Officer and President of Windtree Therapeutics, Inc. since February 1, 2016 and...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 8.8yrs | US$693.63k | 0.099% $ 4.4k | |
Senior VP & COO | 4.7yrs | US$451.73k | 0.00048% $ 21.4 | |
Senior VP & Chief Medical Officer | 10.1yrs | US$491.73k | 0.00070% $ 31.2 | |
Senior VP | 1.3yrs | no data | 0.0065% $ 290.0 | |
Vice President of Technical Operations | no data | no data | no data | |
Executive Director of Clinical Development | 4.3yrs | no data | no data | |
Head of Operations & Program Management | 4.3yrs | no data | no data |
4.5yrs
Average Tenure
59yo
Average Age
Experienced Management: WINT's management team is considered experienced (4.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 8.8yrs | US$693.63k | 0.099% $ 4.4k | |
Lead Independent Director | 1.4yrs | US$32.34k | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data |
0.8yrs
Average Tenure
53.5yo
Average Age
Experienced Board: WINT's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.